Cargando…
Subcutaneous Tocilizumab May Be Effective in Refractory Fibromyalgia Patients
Introduction: Fibromyalgia (FM) is a chronic disorder characterized by widespread pain with an enormous symptom burden. Its treatment efficacy is limited. Its pathogenesis involves immune dysregulation, which includes interleukin-6 (IL-6) production. Methods: We herein reported a case series of FM p...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376766/ https://www.ncbi.nlm.nih.gov/pubmed/37509414 http://dx.doi.org/10.3390/biomedicines11071774 |